Therapeutic efficacy of unilateral subthalamotomy in Parkinson's disease: Results in 89 patients followed for up to 36 months

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 80, Issue 9, 2009, Pages 979-985

  Alvarez, L ^a   Macias, R ^a   Pavon N ^a   Lopez G ^a   Rodriguez Oroz M C ^b,c   Rodriguez R ^a   Alvarez, M ^a   Pedroso, I ^a   Teijeiro, J ^a   Fernandez R ^a   Casabona, E ^a   Salazar, S ^a   Maragoto, C ^a   Carballo, M ^a   Garcia I ^a   Guridi, J ^b,c   Juncos, J L ^d   DeLong, M R ^d   Obeso, J A ^b,c  

^a CENTRO INTERNACIONAL DE RESTAURACIÓN NEUROLÓGICA CIREN   (Cuba)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENSERAZIDE; BROMOCRIPTINE; LEVODOPA; PERGOLIDE; ANTIPARKINSON AGENT;

ADULT; AGED; ARTICLE; BRAIN SURGERY; CHOREA; CLINICAL TRIAL; COGNITION; DYSARTHRIA; DYSKINESIA; FEMALE; FOLLOW UP; HEMIBALLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; PALLIDOTOMY; PARKINSON DISEASE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SEIZURE; SUBTHALAMIC NUCLEUS; SUBTHALAMOTOMY; SURGICAL INFECTION; SURGICAL RISK; TREATMENT OUTCOME; UNIFIED PARKINSON DISEASE RATING SCALE; DAILY LIFE ACTIVITY; DRUG RESISTANCE; MIDDLE AGED; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; STEREOTACTIC PROCEDURE;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ANTIPARKINSON AGENTS; COGNITION; DRUG RESISTANCE; DYSKINESIAS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEVODOPA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; PARKINSON DISEASE; STEREOTAXIC TECHNIQUES; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

EID: 69449095866     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2008.154948     Document Type: Article

References (39)

1. DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990;13:281-285
2. Vila M, Levy R, Herrero MT, et al. Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA. J Neurosci 1997;17:765-773 (Pubitemid 27024588)
3. Hutchison WD, Allan RJ, Opitz H, et al. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann Neurol 1998;44:622-628 (Pubitemid 28477849)
4. Rodriguez-Oroz MC, Rodriguez M, Guridi J, et al. The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics. Brain 2001;124:1777-1790 (Pubitemid 32845439)
5. Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990;249:1436-1438 (Pubitemid 20341910)
6. Aziz TZ, Peggs D, Sambrook MA, et al. Lesion of subthalamic nucleus for the alleviation of 1-methyl-4-phenyl; 1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov Disord 1991;6:288-293
7. Guridi J, Herrero MT, Luquin MR, et al. Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis. Brain 1996;119:1717-1727
8. Guridi J, Herrero MT, Luquin MR, et al. The subthalamic nucleus: a new possible stereotaxic target for Parkinson's disease. Mov Disord 1993;8:421-429 (Pubitemid 23291193)
9. Dierssen G, Bergmann L, Gioino L, et al. Hemiballism following surgery for Parkinson's disease. Arch Neurol 1961;5:627-637
10. Guridi J, Obeso JA. The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurosurgical dogma. Brain 2001;124:5-19. (Pubitemid 32055985)
11. Gill SS, Heywood P. Bilateral dorsolateral subthalamotomy for advanced Parkinson's disease. Lancet 1997;350:1224. (Pubitemid 127445101)
12. Obeso JA, Alvarez L, Macias R, et al. Lesion of the subthalamic nucleus (STN) in Parkinson's disease (PD). Neurology 1997;48(Suppl 3):138A.
13. Alvarez L, Macias R, Guridi J, et al. Dorsal subthalamotomy for Parkinson's disease. Mov Disord 2001;16:72-78
14. Patel NK, Heywood P, O'Sullivan K, et al. Unilateral subthalamotomy in the treatment of Parkinson's disease. Brain 2003;126:1136-1145 (Pubitemid 36522956)
15. Su PC, Tseng HM, Liu HM, et al. Subthalamotomy for advanced Parkinson disease. J Neurosurg 2002;97:598-606.
16. Vilela F, da Silva DJ. Unilateral subthalamic nucleus lesioning: a safe and effective treatment for Parkinson's disease. Arq Neuropsiquiatr 2002;60:935-948 (Pubitemid 35439737)
17. Alvarez L, Macias R, Lopez G, et al. Bilateral subthalamotomy in Parkinson's disease: initial and long-term response. Brain 2005;128:570-583 (Pubitemid 40380192)
18. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184
19. Lopez-Flores G, Morales JM, Tejeiro-Amador J, et al. Anatomic and neurophysiological methods for the targeting and lesioning of the subthalamic nucleus: Cuban experience and review. Neurosurgery 2002;52:817-829 (Pubitemid 36402869)
20. Macias R, Teijeiro R, Torres A, et al. Electrophysiological targeting in stereotaxic surgery for Parkinson's disease. Adv Neurol 1997;74:175-182
21. Teijeiro J, Macias R, Morales JM, et al. Personal-computer-based system for three-dimensional anatomic-physiological correlations during stereotactic functional neurosurgery. Stereotact Funct Neurosurg 2000;75:176-187 (Pubitemid 34702081)
22. Carballo-Barreda M, Rodríguez-Rojas R, Lopez G, et al. Sistema tridimensional de planeamiento quirúrgico para PC. Ingeniería Electrónica Automática y Comunicaciones 2005;26:19-23
23. Langston JW, Widner H, Goetz CG, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992;7:2-13.
24. Goetz CG, Stebbins GT, Shale HM, et al. Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment. Mov Disord 1994;9:390-394
25. Bickel S, Fernandez C, Alvarez L, et al. Cognitive and neuropsychiatric effects of subthalamotomy for Parkinson disease. Parkinsonism Relat Disord (in press).
26. Fraix V, Pollak P, Van Blercom N, et al. Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson's disease. Neurology 2000;55:1921-1923 (Pubitemid 32103981)
27. Vingerhoest FJG, Villemure JG, Temperli P, et al. Subthalamic DBS replaces levodopa in Parkinson's patients. Two years follow up. Neurology 2002;58:396-401.
28. Guridi J, Obeso JA, Rodriguez-Oroz MC, et al. L-Dopa-induced dyskinesia and stereotactic surgery for Parkinson's disease. Neurosurgery 2008;62:311-325
29. Mouradian MM, Juncos JL, Fabbrini G, et al. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms Part II. Ann Neurol 1988;24:372-378 (Pubitemid 18233136)
30. McCarter RJ, Walton NH, Rowan AF, et al. Cognitive functioning after subthalamic nucleotomy for refractory Parkinson's disease. J Neurol Neurosurg Psychiatry 2000;69:60-66
31. Fine J, Duff J, Chen R, et al. Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease. N Engl J Med 2000;342:1708-1714 (Pubitemid 30354518)
32. Krack P, Batir A, Van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003;349:1925-1934 (Pubitemid 37409709)
33. Rodriguez-Oroz MC, Obeso JA, Lang AE, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 2005;128:2240-2249 (Pubitemid 41407964)
34. Suarez JI, Metman LV, Reich SG, et al. Pallidotomy for hemiballismus: efficacy and characteristics of neuronal activity. Ann Neurol 1997;42:807-811
35. Vitek JL, Chockkan V, Zhang JY, et al. Neuronal activity in the basal ganglia in patients with generalized dystonia and hemiballismus. Ann Neurol 1999;46:22-35. (Pubitemid 29314379)
36. Lozano AM. The subthalamic nucleus. Myth and opportunities. Mov Disord 2001;16:183-184
37. Herzog J, Pinsker M, Wasner M, et al. Stimulation of subthalamic fibre tracts reduces dyskinesias in STN-DBS. Mov Disord 2007;22:679-684 (Pubitemid 46800138)
38. Gioino GG, Dierssen G, Cooper IS. The effect of subcortical lesions on production and alleviation of hemiballistic or hemichoreic movements. J Neurol Sci 1966;3:10-36.
39. Guridi J, Obeso JA. The subthalamic nucleus, hemiballismus and Parkinson's disease: reappraisal of a neurosurgical dogma. Brain 2001;124:5-19. (Pubitemid 32055985)